Krsnaa Diagnostics Seeks Shareholder Approval for Director Appointments and Director Remuneration
Krsnaa Diagnostics is seeking shareholder approval via postal ballot for director re-appointments and remuneration. Key proposals include re-appointing Chetan Desai as Independent Director for five years and appointing Raju Venkatraman and Lilian Jessie Paul for two years. Shareholders will also vote on a commission payment to Independent Directors, capped at ₹50 Lakhs annually. E-voting is open from June 5 to July 4, 2026.
The appointment of directors and the approval of their remuneration are significant for the company's governance structure and future strategic direction. However, the impact is considered medium as these are standard corporate actions and do not represent a major shift in business operations or financial performance.
The announcement pertains to routine corporate governance matters, including director appointments and remuneration, which are standard procedures for companies. There are no immediate positive or negative financial implications mentioned.
Krsnaa Diagnostics Limited has issued a Notice of Postal Ballot to seek shareholder approval for several key matters. The company is proposing the re-appointment of Mr. Chetan Desai as a Non-Executive Independent Director for a second term of five years, effective from April 25, 2026, to April 24, 2031. Additionally, the company seeks approval for the appointment of Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Non-Executive Independent Directors for a period of two years, each from April 25, 2026, to April 24, 2028.
Furthermore, shareholders will vote on a proposal to approve the payment of remuneration by way of commission to Independent Directors. This commission, in addition to sitting fees, will not exceed 1% of the company's net profits, capped at ₹50,00,000 annually, commencing from the financial year 2026-27.
The e-voting period for these resolutions will commence on Friday, June 05, 2026, at 09:00 Hrs. (IST) and conclude on Saturday, July 04, 2026, at 17:00 Hrs. (IST). The cut-off date for determining eligibility for e-voting was Friday, May 29, 2026. The results of the e-voting will be announced within two working days of the conclusion of the voting period.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.